Latest News

Kathryn Marshall, Quality Manager and Chris McCarthy Development & Manufacturing Manager pictured during BeadBot's™ installation at Biofortuna's main laboratory.   Point of Care diagnostics is reshaping the way healthcare is delivered, driving demand for faster results, decentralised testing, and scalable manufacturing. To meet this demand we have developed a bespoke robotic manufacturing and quality control system which will increase lyoRead more

2025 has been an incredible for Biofortuna, marked by continued collaboration with some of the most innovative influential companies within diagnostics, food safety, DNA testing and healthcare. We’ve done this while maintaining our focus on quality, reliability and innovation, delivering solutions that help bring life changing innovations to market faster. At the heart of this progress is our commitment toRead more

Welsh Government ministers Jack Sergeant MS (fourth from left) and Ken Skates (third from right) pictured with members of the Biofortuna team during their recent site visit.   Biofortuna, a leading diagnostics manufacturer and laboratory services provider, welcomed Welsh Government Ministers Ken Skates MS and Jack Sargeant MS on Monday (8th December) to demonstrate how the Deeside-based CDMO is playing

Read more

We are delighted to announce that we are ISO 14001:2015 compliant! This internationally recognised standard for environmental management systems (EMS) reflects our ongoing commitment to minimising our environmental impact, reducing waste and promoting long-term sustainability across our operations. The ISO 14001 framework supports organisations in managing their environmental responsibilities in an efficient way. For Biofortuna, this confirms that our operations

Read more

Additional Lyo bead automation ramps up manufacturing capacity to over half a million tests per day.   Biofortuna Limited (Deeside, UK), the specialist contract development and manufacturing partner to the IVD and point of care testing sectors, has invested in an additional Lyo bead manufacturing line in response to increasing customer demand for lyophilized diagnostic tests.   The new, fully

Read more

We are delighted to share the news that hot on the heels of our 2023 Technical Service Award win, we have again been shortlisted for the 2024 Bionow Awards, this year for Business Internationalisation.   Now in their 23rd year, the Bionow awards celebrate the innovation and impact of the Life Sciences sector.   A panel of judges reviewed detailed

Read more

What is lyophilization? Lyophilization is the process of removing water from a product to the point where it is no longer biologically or chemically active. Lyophilization of an assay prevents degradation of its components such as enzymes, antibodies, proteins, DNA or oligonucleotides, allowing them to be safely transported and stored at room temperature with no loss in performance.   ThreeRead more

The rapidly growing Lyo beads market  The global Lyophilised Reagent Beads market was valued at USD 188 Million in 2023 and is anticipated to reach USD 380 Million by 2030, witnessing a CAGR of 11.0% during the forecast period 2024-2030. This significant growth is driven by various factors: Rising demand in molecular diagnostics: Lyophilised reagent beads offer greater stability and longer shelf-life compared

Read more

Deeside, Wales 9, May 2024: Biofortuna Limited, the specialist laboratory services and CDMO, has completed the acquisition of Cryoniss Ltd, underlining its commitment to support life-changing research and development across the global biotech and life sciences sector. The acquisition of Cryoniss brings expertise and infrastructure in temperature-controlled biological sample storage, strengthening Biofortuna’s existing stability storage capability and accelerating the growth

Read more

We would like to extend a big Biofortuna welcome to Corinne Niger and Sarah Sadler as they become the latest additions to our European sales team. Corinne joins us from a similar role at Oxford Nanopore and has extensive experience in sales development and project scientist roles. Sarah arrives from LGC Biosearch Technologies having previously been at Meridian Bioscience. Together

Read more